INITIAL 13G

Company

Vanda Pharmaceuticals Inc.

Filed

February 7, 2007

Accession Number

0000728889-07-000176

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →